Legal Representation
Attorney
Quan Nguyen
USPTO Deadlines
Next Deadline
2167 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-01)
Due Date
July 01, 2031
Grace Period Ends
January 01, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 1, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 1, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 20, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 20, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 20, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 13, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 13, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 7, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 10, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 10, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 10, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 10, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 10, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 1, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 6, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 6, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biochemical substrates for scientific research purposes, namely, peptides, oligonucleotides, and bioconjugates
First Use Anywhere:
20240900
First Use in Commerce:
20240900
Class 042
Biochemical research and development; Biochemical research and development services, namely the development of custom peptides, custom oligonucleotides, and custom bioconjugates
First Use Anywhere:
20240900
First Use in Commerce:
20240900
Classification
International Classes
001
042